Global Secretome Characterization of the Pathogenic Yeast Candida glabrata | Journal of Proteome Research
Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes | Scientific Reports
Protease expression by microorganisms and its relevance to crucial physiological/pathological events
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases Margarete Borg-von Zepelin, - ppt download
Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection | PLOS Neglected Tropical Diseases
Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery | Journal of Medicinal Chemistry
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases - ScienceDirect
Frontiers | New Insights in Candida albicans Innate Immunity at the Mucosa: Toxins, Epithelium, Metabolism, and Beyond
Molecular docking of the bioactive compound Ocimum sanctum as an inhibitor of Sap 1 Candida albicans | Sasambo Journal of Pharmacy
HIV-Protease Inhibitors Reduce Cell Adherence of Candida Albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases - ScienceDirect
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Molecular docking: Bioactive compounds of Mimosa pudica as an inhibitor of Candida albicans Sap 3 | bioRxiv
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Frontiers | It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
Prevalence of fungal species isolated from HIV and HIV women with... | Download Table
Full article: Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface
HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos
JoF | Free Full-Text | Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
